Bolan Elizabeth A, Kivell Bronwyn, Jaligam Vanaja, Oz Murat, Jayanthi Lankupalle D, Han Yang, Sen Namita, Urizar Eneki, Gomes Ivone, Devi Lakshmi A, Ramamoorthy Sammanda, Javitch Jonathan A, Zapata Agustin, Shippenberg Toni S
Integrative Neuroscience Section, National Institute on Drug Abuse Intramural Research Program/National Institutes of Health/Department of Health and Human Services, Baltimore, MD 21224, USA.
Mol Pharmacol. 2007 May;71(5):1222-32. doi: 10.1124/mol.106.027763. Epub 2007 Jan 31.
The dopamine transporter (DAT) terminates dopamine (DA) neurotransmission by reuptake of DA into presynaptic neurons. Regulation of DA uptake by D(2) dopamine receptors (D(2)R) has been reported. The high affinity of DA and other DAT substrates for the D(2)R, however, has complicated investigation of the intracellular mechanisms mediating this effect. The present studies used the fluorescent DAT substrate, 4-[4-(diethylamino)-styryl]-N-methylpyridinium iodide (ASP(+)) with live cell imaging techniques to identify the role of two D(2)R-linked signaling pathways, extracellular signal-regulated kinases 1 and 2 (ERK1/2), and phosphoinositide 3 kinase (PI3K) in mediating D(2)R regulation of DAT. Addition of the D(2)/D(3) receptor agonist quinpirole (0.1-10 muM) to human embryonic kidney cells coexpressing human DAT and D(2) receptor (short splice variant, D(2S)R) induced a rapid, concentration-dependent and pertussis toxin-sensitive increase in ASP(+) accumulation. The D(2)/D(3) agonist (S)-(+)-(4aR, 10bR)-3,4,4a, 10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano-[4,3-b]-1,4-oxazin-9-ol hydrochloride (PD128907) also increased ASP(+) accumulation. D(2S)R activation increased phosphorylation of ERK1/2 and Akt, a major target of PI3K. The mitogen-activated protein kinase kinase inhibitor 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059) prevented the quinpirole-evoked increase in ASP(+) accumulation, whereas inhibition of PI3K was without effect. Fluorescence flow cytometry and biotinylation studies revealed a rapid increase in DAT cell-surface expression in response to D(2)R stimulation. These experiments demonstrate that D(2S)R stimulation increases DAT cell surface expression and therefore enhances substrate clearance. Furthermore, they show that the increase in DAT function is ERK1/2-dependent but PI3K-independent. Our data also suggest the possibility of a direct physical interaction between DAT and D(2)R. Together, these results suggest a novel mechanism by which D(2S)R autoreceptors may regulate DAT in the central nervous system.
多巴胺转运体(DAT)通过将多巴胺(DA)重新摄取到突触前神经元中来终止多巴胺神经传递。已有报道称D2多巴胺受体(D2R)可调节多巴胺摄取。然而,DA和其他DAT底物对D2R的高亲和力使介导这种作用的细胞内机制的研究变得复杂。本研究使用荧光DAT底物4-[4-(二乙氨基)-苯乙烯基]-N-甲基碘化吡啶鎓(ASP(+))和活细胞成像技术,以确定两条与D2R相关的信号通路,即细胞外信号调节激酶1和2(ERK1/2)以及磷脂酰肌醇3激酶(PI3K)在介导D2R对DAT的调节中的作用。向共表达人DAT和D2受体(短剪接变体,D2SR)的人胚肾细胞中添加D2/D3受体激动剂喹吡罗(0.1 - 10 μM),可诱导ASP(+)积累迅速、浓度依赖性且对百日咳毒素敏感的增加。D2/D3激动剂(S)-(+)-(4aR, 10bR)-3,4,4a,10b-四氢-4-丙基-2H,5H-[1]苯并吡喃并-[4,3-b]-1,4-恶嗪-9-醇盐酸盐(PD128907)也增加了ASP(+)积累。D2SR激活增加了ERK1/2和Akt(PI3K的主要靶点)的磷酸化。丝裂原活化蛋白激酶激酶抑制剂2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮(PD98059)可阻止喹吡罗引起的ASP(+)积累增加,而抑制PI3K则没有效果。荧光流式细胞术和生物素化研究表明,响应D2R刺激,DAT细胞表面表达迅速增加。这些实验表明,D2SR刺激可增加DAT细胞表面表达,从而增强底物清除。此外,它们表明DAT功能的增加是ERK1/2依赖性的,但与PI3K无关。我们的数据还表明DAT和D2R之间可能存在直接的物理相互作用。总之,这些结果提示了一种新的机制,通过该机制D2SR自身受体可能在中枢神经系统中调节DAT。